December 16, 2024 | organ-on-a-chip technology
Ocaliva, Azelaprag, and the Continuing Challenge of Drug-Induced Liver Injury: A Call for Human-Relevant Models
In December, two high-profile drug-induced liver injury (DILI) cases involving Azelaprag and Ocaliva were reported in one week, and at least 11 similar incidents have occurred since 2022. Learn how incorporating predictive, human-relevant models like Organ-Chips could improve drug safety and help to avoid DILI failures.
